Skip to main content

Bridgefront Capital, LLC

SEC CIK
0001725690
Latest filing
Aug 14, 2026

HAE holding history

Haemonetics Corp in every 13F filed by Bridgefront Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HAE overviewAll 13F holders of HAEFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
7
Since Q1 2021
Holdings of HAE by Bridgefront Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−14,363−100.0%Sold outHolders
Q1 202614,363$809.5K0.2%+4,133+40.4%AddedHolders
Q4 202510,230$819.9K0.2%+5,492+115.9%AddedHolders
Q3 20254,738$230.9K0.1%+4,738NewHolders
Q2 20250$00.0%−8,178−100.0%Sold outHolders
Q1 20258,178$519.7K0.2%+3,113+61.5%AddedHolders
Q4 20245,065$395.5K0.1%+5,065NewHolders
Q2 20240$00.0%−3,835−100.0%Sold outHolders
Q1 20243,835$327.3K0.2%+3,835NewHolders
Q2 20210$00.0%−3,574−100.0%Sold outHolders
Q1 20213,574$397.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.